Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of DK001 for complex perianal fistulas in Crohn's disease
CTR20213380Phase 2Active
- Sponsor
- Jiangsu Dekang Biotechnology
- Start
- Apr 2022
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Stem Cell Therapies → Cell Therapies, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of DK001 in Crohn's disease, sponsored by Jiangsu Dekang Biotechnology. Started Apr 2022; status: active.
02
Drugs
DK001
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20213380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213380.